0001547547-17-000001.txt : 20171228 0001547547-17-000001.hdr.sgml : 20171228 20171228161059 ACCESSION NUMBER: 0001547547-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171228 DATE AS OF CHANGE: 20171228 EFFECTIVENESS DATE: 20171228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Millendo Therapeutics, Inc. CENTRAL INDEX KEY: 0001547547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454492412 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-301902 FILM NUMBER: 171278540 BUSINESS ADDRESS: STREET 1: 301 NORTH MAIN STREET STREET 2: SUITE 100 CITY: ANN ARBOR STATE: MI ZIP: 48104 BUSINESS PHONE: (734) 845-9000 MAIL ADDRESS: STREET 1: 301 NORTH MAIN STREET STREET 2: SUITE 100 CITY: ANN ARBOR STATE: MI ZIP: 48104 FORMER COMPANY: FORMER CONFORMED NAME: Atterocor, Inc. DATE OF NAME CHANGE: 20120417 D 1 primary_doc.xml X0708 D LIVE 0001547547 Millendo Therapeutics, Inc. 301 NORTH MAIN STREET SUITE 100 ANN ARBOR MI MICHIGAN 48104 (734) 845-9000 DELAWARE Atterocor, Inc. Corporation true Julia Owens 301 N. Main Street Suite 100 Ann Arbor MI MICHIGAN 48104 Executive Officer Director Carol Gallagher 301 N. Main Street Suite 100 Ann Arbor MI MICHIGAN 48104 Director James Topper 301 N. Main Street Suite 100 Ann Arbor MI MICHIGAN 48104 Director Mary Lynne Hedley 301 N. Main Street Suite 100 Ann Arbor MI MICHIGAN 48104 Director Carole Neuchterlein 301 N. Main Street Suite 100 Ann Arbor MI MICHIGAN 48104 Director Randall Whitcomb 301 N. Main Street Suite 100 Ann Arbor MI MICHIGAN 48104 Director James Hindman 301 N. Main Street Suite 100 Ann Arbor MI MICHIGAN 48104 Director Thierry Abribat 301 N. Main Street Suite 100 Ann Arbor MI MICHIGAN 48104 Director Pharis Mohideen 301 N. Main Street Suite 100 Ann Arbor MI MICHIGAN 48104 Executive Officer Christopher Seiter 301 N. Main Street Suite 100 Ann Arbor MI MICHIGAN 48104 Executive Officer Jeffery Brinza 301 N. Main Street Suite 100 Ann Arbor MI MICHIGAN 48104 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2017-12-19 true true true true This offering is being made in connection with a share exchange pursuant to which Millendo Therapeutics, Inc. acquired substantially all of the outstanding stock of Alize Pharma SAS. 0 59109960 50043201 9066759 true 8 14 0 0 0 false Millendo Therapeutics, Inc. /s/Julia Owens Julia Owens President and Chief Executive Officer 2017-12-28